<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Vaccines : People and places : Geographical locations : Africa:" exact="Sierra Leone" post=": Medicine and Health Sciences : Tropical Diseases :"/>
 <result pre="– review &amp;amp; editing2[1], SmartAnalyst Inc., New York, New York," exact="United States" post="of America[2], SmartAnalyst India Pvt. Ltd., Gurgaon, India[3], Janssen"/>
 <result pre="Inc., New York, New York, United States of America[2], SmartAnalyst" exact="India" post="Pvt. Ltd., Gurgaon, India[3], Janssen Vaccines &amp;amp; Prevention, Raritan,"/>
 <result pre="Ltd., Gurgaon, India[3], Janssen Vaccines &amp;amp; Prevention, Raritan, New Jersey," exact="United States" post="of America[4], Janssen Vaccines &amp;amp; Prevention B.V., Leiden, The"/>
 <result pre="developed for this purpose and validated by simulating the 2014" exact="Sierra Leone" post="epidemic. We assessed the impacts of prophylactic vaccination of"/>
 <result pre="intervals [CI]: 478–21,942) cases and 3,575 (95%CI: 179–9,031) deaths in" exact="Sierra Leone," post="in line with WHO-reported statistics for the 2014 epidemic"/>
 <result pre="were employed by Janssen Vaccines &amp;amp; Prevention B.V., Leiden, The" exact="Netherlands" post="and RP, AK, VM and HB were employed by"/>
 <result pre="the later stages that an investigational vaccine was administered in" exact="Guinea" post="and Sierra Leone using a ring vaccination strategy [8,9]."/>
 <result pre="stages that an investigational vaccine was administered in Guinea and" exact="Sierra Leone" post="using a ring vaccination strategy [8,9]. Multiple Ebola vaccine"/>
 <result pre="followed by WHO prequalification), its subsequent independent approval by the" exact="United States" post="Food and Drug Administration, and submission of a prophylactic"/>
 <result pre="areas [12]. The persistent epidemic in the Democratic Republic of" exact="Congo" post="that has been ongoing since August 2018, with approximately"/>
 <result pre="model to reflect a real-life epidemic (we chose the 2014" exact="Sierra Leone" post="epidemic for the size of the epidemic and the"/>
 <result pre="model structure, and identification of data related to the 2014" exact="Sierra Leone" post="epidemic. This was followed by a) fitting of geography-"/>
 <result pre="mean outcomes with confirmed cases and deaths reported for the" exact="Sierra Leone" post="epidemic of 2014 by the WHO [28] and Fang"/>
 <result pre="P, protected. Model parameterization and validation The 2014 epidemic in" exact="Sierra Leone" post="was simulated with the help of disease-specific parameters that"/>
 <result pre="simulations, were compared with WHO data relating to the 2014" exact="Sierra Leone" post="epidemic to check for closeness of fit. Fig 2"/>
 <result pre="of fit. Fig 2 Reported Ebola cases for the 2014" exact="Sierra Leone" post="epidemic–among overall population (weekly cases) and in HCW (monthly"/>
 <result pre="the key model parameters were all based on the 2014" exact="Sierra Leone" post="epidemic. The vaccination strategy related parameters used in the"/>
 <result pre="(general population)/monthly (HCW) cases reported for the 2014 epidemic in" exact="Sierra Leone" post="separately for the three periods of the epidemic can"/>
 <result pre="consistent with previously published estimates of R0 for the 2014" exact="Sierra Leone" post="epidemic (1.26 &amp;lt; R0 &amp;lt; 2.53) [26]. Fig 3"/>
 <result pre="all HCW (115, who represent just 0.0016% of the overall" exact="Sierra Leone" post="population) will help reduce both cases and deaths at"/>
 <result pre="±10% range) in three key parameters fitted for the 2014" exact="Sierra Leone" post="epidemic—transmission rates, time to hospitalization, and time from hospitalization"/>
 <result pre="outbreaks similar to the one in Kikwit, Democratic Republic of" exact="Congo" post="(1995). However, the study concluded that while HCWs play"/>
 <result pre="will be. Kilmarx and colleagues [38], while evaluating the 2014" exact="Sierra Leone" post="epidemic, reported that cumulative incidence in HCW was 8,285"/>
 <result pre="&amp;gt;51% (95% confidence intervals: 44%-56%) of the total population in" exact="Sierra Leone" post="would be sufficient to control the epidemic of Ebola"/>
 <result pre="HCW workforce in the affected countries of Guinea, Liberia, and" exact="Sierra Leone," post="died during the 2014 epidemic [33,40]. This made it"/>
 <result pre="percent of surgeons affiliated with the main teaching hospital in" exact="Sierra Leone" post="died during the epidemic in August 2014, resulting in"/>
 <result pre="in maternal mortality by 38%, 74%, and 111% in Guinea," exact="Sierra Leone," post="and Liberia, respectively, translating to 4,022 additional maternal deaths"/>
 <result pre="outbreak, and 3) the impact of ring vaccination implemented in" exact="Sierra Leone" post="during the 2014 epidemic has been captured during the"/>
 <result pre="vaccine in preventing Ebola virus disease: final results from the" exact="Guinea" post="ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet"/>
 <result pre="14collab: World Health Organization. Ebola virus disease–Democratic Republic of the" exact="Congo" post="Disease outbreak news: Update; 28 February 2019Geneva, Switzerland: World"/>
 <result pre="2018 Ebola virus disease outbreak in Equateur province in the" exact="Democratic Republic of the Congo." post="bioRxiv. 2019:46506210.1101/465062 22WordenL, WannierR, HoffNA, MuseneK, SeloB, MossokoM, et"/>
 <result pre="MartchevaM. Efficacy of control measures in the control of Ebola," exact="Liberia" post="2014–2015. J Biol Dyn. 2018;12(1):913–37. Epub 2018/10/26. 10.1080/17513758.2018.153509530355048 24WellsCR,"/>
 <result pre="PandeyA, ParpiaAS, FitzpatrickMC, MeyersLA, SingerBH, et al.Ebola vaccination in the" exact="Democratic Republic of the Congo." post="Proceedings of the National Academy of Sciences of the"/>
 <result pre="Congo. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America. 2019;116(20):10178–83. Epub 2019/05/01. 10.1073/pnas.181732911631036657 25RobertA, CamachoA, EdmundsWJ,"/>
 <result pre="The potential impact of a prophylactic vaccine for Ebola in" exact="Sierra Leone." post="Mathematical biosciences and engineering: MBE. 2018;15(2):337–59. Epub 2017/11/23. 10.3934/mbe.201801529161839"/>
 <result pre="al.Transmission dynamics of Ebola virus disease and intervention effectiveness in" exact="Sierra Leone." post="Proceedings of the National Academy of Sciences of the"/>
 <result pre="Leone. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America. 2016;113(16):4488–93. Epub 2016/04/02. 10.1073/pnas.151858711327035948 30GillespieDT. A general"/>
 <result pre="Ebola: how events impacted on a single surgical institution in" exact="Sierra Leone." post="J R Army Med Corps. 2016;162(3):212–6. Epub 2016/01/21. 10.1136/jramc-2015-00058226787775"/>
</results>
